Literature DB >> 9659166

Identification of distinct upper and lower gastrointestinal symptom groupings in an urban population.

N J Talley1, P Boyce, M Jones.   

Abstract

BACKGROUND: The current classification dividing patients with functional gastrointestinal symptoms into subgroups remains controversial. AIMS: To determine whether distinct symptom groupings exist in the community.
METHODS: A random sample of Sydney residents in Penrith, Australia was mailed a validated self report questionnaire. Gastrointestinal symptoms including the Rome criteria for irritable bowel syndrome (IBS) and dyspepsia were measured.
RESULTS: Among 730 respondents, the 12 month age and gender adjusted prevalence (adjusted to the Australian population) of IBS, dyspepsia, and gastro-oesophageal reflux were 11.8% (95% confidence interval (CI) 9.3 to 14.3%), 11.5% (95% CI 9.6 to 14.6%), and 17.5% (95% CI 14.2 to 19.9%), respectively. In total, 60% of the population reported four or more gastrointestinal symptoms. There was considerable overlap of IBS with dyspepsia and among the dyspepsia subgroups by application of the Rome criteria. Independently, 10 symptom groupings were identified by factor analysis. The underlying constructs measured by these factors were generally the major abdominal syndromes recognised by the Rome classification: dyspepsia, IBS, reflux, painless constipation, painless diarrhoea, and bloating, in addition to a number of more specific symptom groupings.
CONCLUSION: Gastrointestinal symptoms are common and overlap in the community, but distinct upper and lower abdominal symptom groupings can be identified.

Entities:  

Mesh:

Year:  1998        PMID: 9659166      PMCID: PMC1727099          DOI: 10.1136/gut.42.5.690

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  23 in total

1.  Diagnostic value of the Manning criteria in irritable bowel syndrome.

Authors:  N J Talley; S F Phillips; L J Melton; C Mulvihill; C Wiltgen; A R Zinsmeister
Journal:  Gut       Date:  1990-01       Impact factor: 23.059

Review 2.  What are functional bowel disorders?

Authors:  J Zighelboim; N J Talley
Journal:  Gastroenterology       Date:  1993-04       Impact factor: 22.682

3.  Dyspepsia and dyspepsia subgroups: a population-based study.

Authors:  N J Talley; A R Zinsmeister; C D Schleck; L J Melton
Journal:  Gastroenterology       Date:  1992-04       Impact factor: 22.682

4.  Is the association between irritable bowel syndrome and abuse explained by neuroticism? A population based study.

Authors:  N J Talley; P M Boyce; M Jones
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

5.  Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples.

Authors:  W E Whitehead; M D Crowell; L Bosmajian; A Zonderman; P T Costa; C Benjamin; J C Robinson; B R Heller; M M Schuster
Journal:  Gastroenterology       Date:  1990-02       Impact factor: 22.682

6.  Epidemiology of colonic symptoms and the irritable bowel syndrome.

Authors:  N J Talley; A R Zinsmeister; C Van Dyke; L J Melton
Journal:  Gastroenterology       Date:  1991-10       Impact factor: 22.682

Review 7.  Irritable bowel syndrome in the elderly.

Authors:  E O'Keefe; N J Talley
Journal:  Clin Geriatr Med       Date:  1991-05       Impact factor: 3.076

8.  Irritable bowel syndrome in the general population.

Authors:  R Jones; S Lydeard
Journal:  BMJ       Date:  1992-01-11

9.  Functional bowel disorders in apparently healthy people.

Authors:  W G Thompson; K W Heaton
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

10.  How bad are the symptoms and bowel dysfunction of patients with the irritable bowel syndrome? A prospective, controlled study with emphasis on stool form.

Authors:  K W Heaton; S Ghosh; F E Braddon
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

View more
  51 in total

Review 1.  Natural history of dyspepsia.

Authors:  Lars Agréus
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

2.  Irritable bowel syndrome: patterns of ambulatory health care and resource use in the United States, 1993-1997.

Authors:  Jennifer Hollowell; Annika Lundgren; Saga Johansson
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

Review 3.  Irritable bowel syndrome and functional dyspepsia: different diseases or a single disorder with different manifestations?

Authors:  Laura Noddin; Michael Callahan; Brian E Lacy
Journal:  MedGenMed       Date:  2005-08-29

Review 4.  Functional esophageal disorders.

Authors:  R E Clouse; J E Richter; R C Heading; J Janssens; J A Wilson
Journal:  Gut       Date:  1999-09       Impact factor: 23.059

5.  Chronic prenatal stress epigenetically modifies spinal cord BDNF expression to induce sex-specific visceral hypersensitivity in offspring.

Authors:  J H Winston; Q Li; S K Sarna
Journal:  Neurogastroenterol Motil       Date:  2014-03-04       Impact factor: 3.598

Review 6.  Restriction of FODMAP in the management of bloating in irritable bowel syndrome.

Authors:  Wei Mon Wong
Journal:  Singapore Med J       Date:  2016-09       Impact factor: 1.858

7.  Composite score of reflux symptoms in diagnosis of gastroesophageal reflux disease.

Authors:  Jin-Hai Wang; Jin-Yan Luo; Lei Dong; Jun Gong; Ai-Li Zuo
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

8.  Influence of functional bowel disease on outcome of surgical antireflux procedures.

Authors:  David A Axelrod; Vasu Divi; Majet M Ajluni; Frederic E Eckhauser; Lisa M Colletti
Journal:  J Gastrointest Surg       Date:  2002 Jul-Aug       Impact factor: 3.452

9.  Irritable bowel syndrome is more common in women regardless of the menstrual phase: a Rome II-based survey.

Authors:  Sun-Young Lee; Jeong Hwan Kim; In-Kyung Sung; Hyung Seok Park; Choon-Jo Jin; Won Hyeok Choe; So Young Kwon; Chang Hong Lee; Kyoo Wan Choi
Journal:  J Korean Med Sci       Date:  2007-10       Impact factor: 2.153

10.  Assessment of functional gastrointestinal disorders using the Gastro-Questionnaire.

Authors:  Rolf Leibbrand; Ulrich Cuntz; Wolfgang Hiller
Journal:  Int J Behav Med       Date:  2002
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.